Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial

Abstract

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.

Keywords

• Phase
• study
• erlotinib
• combination
• cisplatin
• gemcitabine
• advanced
• non-small-cell
• cancer
• Tarceva
• Cancer
• Investigation
• Trial